「no」の検索結果
166件：61～65件目を表示
-
お知らせ | 千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/english/news/ -
Milestones in Our History | About Senju | SENJU Pharmaceutical
1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb...
https://www.senju.co.jp/english/about/history.html -
Management Policy | About Senju | SENJU Pharmaceutical
iewpoints is the starting point for all our business activities. "If I were you"We should not do to others what we would not like to be done to us.We should do to others what would make us h...
https://www.senju.co.jp/english/about/philosophy.html -
Management Policy | About Senju | SENJU Pharmaceutical
iewpoints is the starting point for all our business activities. "If I were you"We should not do to others what we would not like to be done to us.We should do to others what would make us h...
http://www.senju.co.jp/english/about/philosophy.html -
Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
ors, employees and other members of Senju Pharmaceutical Co., Ltd. (“SENJU”) will act in compliance not only with the law but will operate under a high standard of ethical values so as to conduct busi...
https://www.senju.co.jp/english/about/csr03.html